Albinism overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Albinism}}
{{Albinism}}
{{CMG}}
{{CMG}}; {{AE}}
 
{{PleaseHelp}}


==Overview==
==Overview==
Line 25: Line 27:


==Diagnosis==
==Diagnosis==
===Diagnosis Criteria===


===History and Symptoms===
===History and Symptoms===
Line 31: Line 34:


===Laboratory Findings===
===Laboratory Findings===
===Electrocardiogram===
===Chest X Ray===
===CT===
===MRI===
===Echocardiography or Ultrasound===


===Other Imaging Findings===
===Other Imaging Findings===
Line 47: Line 40:


==Treatment==
==Treatment==
===Medical Therapy===


===Surgery===
===Surgery===
===Medical Therapy===


===Primary Prevention===
===Primary Prevention===


===Secondary Prevention===
===Secondary Prevention===
===Cost-Effectiveness of Therapy===
===Future or Investigational Therapies===


==Case Studies==
==Case Studies==
Line 65: Line 54:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WS}}
{{WH}}


[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Needs content]]
[[Category:Needs content]]
{{WS}}
{{WH}}

Revision as of 12:42, 21 July 2016

Albinism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Albinism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Albinism overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Albinism overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Albinism overview

CDC on Albinism overview

Albinism overview in the news

Blogs on Albinism overview

Directions to Hospitals Treating Albinism

Risk calculators and risk factors for Albinism overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Albinism (from Latin albus; extended etymology), more technically hypomelanism or hypomelanosis, is a form of hypopigmentary congenital disorder, characterized by a lack of melanin pigment in the eyes, skin and hair (or more rarely the eyes alone). Albinism results from inheritance of recessive genes. The condition is known to affect mammals, fish, birds, reptiles, and amphibians. While the most common term for an organism affected by albinism is "albino" (noun and adjective), the word is sometimes used in a derogatory way towards people; more neutral terms are "albinistic" (adjective) and "person with albinism" (noun). Additional clinical adjectives sometimes used to refer to animals are "albinoid" and "albinic".

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Albinism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnosis Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

References

Template:WS Template:WH